News About: Goverment
Stem cell technology higher but not for new drug development.
The level of embryo stem cell technology in Korea showed very high but not for the new drug development, indicating that in one way or others a certain supporting policy should be measured as early as possible.
The...
KFDA to legislate new health food rules
The Korea Food and Drug Administration said on January 3 that it will legislate a bill to revise the standard and specification of functional health foods to ensure its safety and functionality for the people's health...
National Assembly nods a bill to extend tax benefits for drug R&D outlays
The National Assembly passed a bill to extend a sunset period of drug R&D expenditures related to a special tax law for three years, providing the domestic pharmaceutical industry with tax benefits of 283.4 billion wo...
2188 oriental medicines to be reviewed in 2009
The Korea Food and Drug Administration (KFDA) said on January 3 it plans to re-evaluate a total of 2,188 oriental medicines from 31 therapeutic categories in 2009.
- Drugs acting on nervous system and sensory org...
Drug identification system to be compulsory for non-reimbursable OTCs
The Korea Food and Drug Administration said on January 2 that it would revise the current drug identification system, in which manufacturers of over-the-counter (OTC) drugs will be required to indicate their OTC dosag...
504 drugs must pass through bio equivalency tests.
Pursuant to the working rules of Pharmaceutical Affairs Act, the KFDA announced on Dec. 27 that all generic drugs containing the total 504 active ingredients should attach its bio equivalency data at the time of produ...
Non-prescription drugs to register by 6% only.
The new registration of non-prescription drugs this year showed merely 6% out of the total number of drug registrations, indicating a serious non-prescription drug business especially in the critically low birth rate...
New drug-pricing policy to go into effect from December 29
The government said on December 27 it will implement controversial drug pricing and reimbursement policies, called the positive list system from December 29, according to the Ministry of Health and Welfare.
The pos...
Small- and mid-size hospitals to conduct clinical trials for medical device
The Korea Food and Drug Administration said it has formulated a rule to allow eligible small- and mid-size hospitals to conduct their clinical trials for medical device as part of efforts to improve the infrastructure...
Cancerous 22 hair dyes to be banned
Legal standards for a ban on cancer-inducing 22 hair dyes during a long-term use, including smoking cessation aids, will be established and go into effect in the first half of next year based on the EC Directive, the ...
